Page last updated: 2024-08-18

isomethyleugenol and Cancer, Second Primary

isomethyleugenol has been researched along with Cancer, Second Primary in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	1 (14.29)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akaike, M; Kameda, Y; Masuda, M; Miyagi, Y; Morinaga, S; Nakamura, Y; Numata, M; Oshima, T; Rino, Y; Sakuma, Y; Shiozawa, M; Tamagawa, H; Yamamoto, N; Yoshihara, M; Yukawa, N	1
Ando, T; Asada, K; Fujishiro, M; Gotoda, T; Ichinose, M; Maeda, M; Maekita, T; Nakajima, T; Nanjo, S; Oda, I; Shimazu, T; Ushijima, T; Yamamichi, N; Yokoi, C; Yoshida, T	1
Forestier, E; Kristinsson, J; Schmiegelow, K; Söderhäll, S; Vettenranta, K; Weinshilboum, R; Wesenberg, F	1
Akaike, M; Imada, T; Kameda, Y; Masuda, M; Miyagi, Y; Morinaga, S; Nakamura, Y; Oshima, T; Sakuma, Y; Shiozawa, M; Tamagawa, H; Yoshihara, M	1
Batchelor, TT; Louis, DN; Sorensen, AG	1
Bekri, S; Candito, M; Chambon, P; Deville, A; Soler, C; Thyss, A	1
Imaoka, S; Inaji, H; Koyama, H; Motomura, K; Noguchi, S	1

Trials

1 trial(s) available for isomethyleugenol and Cancer, Second Primary

Article	Year
Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia, 2009, Volume: 23, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Child; Child, Preschool; DNA Damage; Female; Genotype; Humans; Inactivation, Metabolic; Infant; Male; Mercaptopurine; Methylation; Methyltransferases; Neoplasm Proteins; Neoplasms, Second Primary; Polymorphism, Genetic; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; Scandinavian and Nordic Countries; Thioguanine	2009

Article

Year

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Leukemia, 2009, Volume: 23, Issue:3

Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Child; Child, Preschool; DNA Damage; Female; Genotype; Humans; Inactivation, Metabolic; Infant; Male; Mercaptopurine; Methylation; Methyltransferases; Neoplasm Proteins; Neoplasms, Second Primary; Polymorphism, Genetic; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; Scandinavian and Nordic Countries; Thioguanine

2009

Other Studies

6 other study(ies) available for isomethyleugenol and Cancer, Second Primary

Article	Year
Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2013, Volume: 39, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Colorectal Neoplasms; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Lysine; Male; Methylation; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Polycomb Repressive Complex 2; Prognosis; Retrospective Studies; Risk Factors; Tissue Array Analysis	2013
High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study. Gut, 2017, Volume: 66, Issue:9 Topics: Follow-Up Studies; Gastroscopy; Humans; Methylation; Neoplasms, Second Primary; Prospective Studies; Retrospective Studies; Stomach Neoplasms	2017
The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer. Oncology reports, 2012, Volume: 27, Issue:3 Topics: Acetylation; Colorectal Neoplasms; Female; Histones; Humans; Immunohistochemistry; Liver Neoplasms; Lysine; Male; Methylation; Middle Aged; Neoplasms, Second Primary; Prognosis; Protein Processing, Post-Translational; Retrospective Studies; Survival Rate	2012
Case records of the Massachusetts General Hospital. Case 17-2012. A 54-year-old man with visual-field loss and a mass in the brain. The New England journal of medicine, 2012, May-31, Volume: 366, Issue:22 Topics: Brain; Brain Neoplasms; Chemoradiotherapy; Diagnosis, Differential; Disease Progression; DNA Modification Methylases; DNA Repair Enzymes; Fatal Outcome; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methylation; Middle Aged; Neoplasms, Second Primary; Recurrence; Tumor Suppressor Proteins; Vision Disorders	2012
Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma. Medical and pediatric oncology, 1996, Volume: 26, Issue:1 Topics: Adrenal Gland Neoplasms; Catecholamines; Dopamine; Ganglioneuroma; Homovanillic Acid; Humans; Infant; Liver Neoplasms; Metanephrine; Methylation; Neoplasms, Second Primary; Neuroblastoma; Normetanephrine; Skin Neoplasms; Vanilmandelic Acid	1996
Differentiation of primary and secondary breast cancer with clonal analysis. Surgery, 1994, Volume: 115, Issue:4 Topics: Base Sequence; Breast Neoplasms; Diagnosis, Differential; Female; Gene Expression Regulation; Genes; Humans; Methylation; Middle Aged; Molecular Probes; Molecular Sequence Data; Neoplasms, Second Primary; Phosphoglycerate Kinase; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; X Chromosome	1994